What are the risks associated with intraoperative hyperglycemia in CABG surgery?
Intraoperative hyperglycemia is associated with an increased morbidity rate in patients with diabetes and with excess mortality in patients with and without diabetes. It is also an independent risk factor for death in patients undergoing cardiac surgery. The Portland Diabetes Project has found that decreased target glucose concentrations can reduce morbidity and mortality rates in those undergoing high-risk cardiac surgery. Furthermore, follow-up studies of these subjects have shown that this benefit can persist for up to 4 years. 